Prosecution Insights
Last updated: April 19, 2026

Examiner: SHEIKH, HUMERA N

Tech Center 1700 • Art Units: 1615 1618 1700 1782 1784 1789 1793

This examiner grants 44% of resolved cases

Performance Statistics

43.8%
Allow Rate
-21.2% vs TC avg
244
Total Applications
+2.1%
Interview Lift
1824
Avg Prosecution Days
Based on 240 resolved cases, 2023–2026

Rejection Statute Breakdown

0.1%
§101 Eligibility
13.9%
§102 Novelty
49.5%
§103 Obviousness
23.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17860848 DIRECT ORAL ANTICOAGULANT-ELUTING MEDICAL DEVICE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18247494 PROTEIN-BOUND CANNABINOID FORMULATIONS AND USES THEREOF Non-Final OA YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month